Vestal Point Capital’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
Vestal Point Capital's DRUG Position: Q3 2026 in Review
Vestal Point Capital held its Bright Minds Biosciences (DRUG) position steady in Q3 2026 at 545,000 shares worth $27.2M. The position accounts for 0.7% of the portfolio, ranked #24.
Vestal Point Capital first reported a position in DRUG in Q1 2026 and has held it in 3 quarters since. The position peaked at $38.3M in Q2 2026. 110 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- Vestal Point Capital held 545,000 shares of Bright Minds Biosciences worth $27.2M as of Q3 2026.
- Vestal Point Capital left its Bright Minds Biosciences share count unchanged in Q3 2026.
- Bright Minds Biosciences made up 0.7% of Vestal Point Capital's portfolio in Q3 2026, its #24 holding.
- Vestal Point Capital first reported a position in Bright Minds Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vestal Point Capital's Bright Minds Biosciences position peaked at $38.3M in Q2 2026.
- 110 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.